Our AI-powered technology provides accessible and immediate screening, revolutionizing how we approach identification of conditions such
as obstructive sleep apnea
.webp)
Effortlessly screen for OSA risk during chair side visits
Leverage routine chair-side visits to surface OSA risk early and guide patients toward timely sleep care
.png)
Objective sleep risk detection, built for the pace of primary care
Upstream identification that drives downstream device revenue by
surfacing qualified patients earlier in their care journey across
the care ecosystem
.webp)
Self-funded employers use Soliish to make sleep health accessible at scale improving employee well-being, reducing medical spend, and increasing productivity
Join a growing network of healthcare organizations using Soliish to improve sleep apnea identification,
streamline workflows, and drive better patient outcomes.
.webp)
.png)
.png)
.svg){kind=small}
.svg){kind=small}
.svg){kind=small}
.svg){kind=small}
.svg){kind=small}
.svg){kind=small}
Bringing sleep apnea screening into everyday dental care
Dental practices are well positioned to identify sleep apnea risk early. You see patients regularly. You evaluate craniofacial anatomy. You hear about fatigue, snoring, and dry mouth long before a diagnosis is made.
Soliish makes it simple to add structured sleep apnea screening to your existing workflow without changing your scope of practice or adding extra administrative burden.
By connecting screening to appropriate medical evaluation, Soliish supports early identification, clear referrals, and coordinated care with sleep physicians while keeping clinical roles clearly defined.
Reduce fatigue-related costs. Improve productivity and wellness.
Integrate sleep screening and care seamlessly into any app or digital platform.
From weight management and mental health to cardiometabolic and wellness platforms, digital health innovators integrate Soliish to expand their offerings.
Our facial-scan AI and automated workflows make it simple to add sleep health screening and routing into any virtual care experience.
AI is revolutionizing diagnostics, boosting efficiency, and improving patient outcomes making it impossible for healthcare providers to overlook its impact.
Our technology has been clinically validated with accuracy comparable to traditional OSA screening tools. The AI-powered analysis detects subtle facial features and patterns associated with OSA risk factors, helping identify individuals who may benefit from further evaluation.
No. The Soliish scan is a screening tool, not a diagnostic device. It identifies individuals who may be at risk for obstructive sleep apnea (OSA) and guides them toward appropriate diagnostic testing such as a home sleep test or polysomnography.
Once the screening is complete, users receive an OSA risk score classified as low, moderate, or high risk. Those identified at risk can be directed to a licensed provider or home sleep test for diagnostic confirmation and care planning. The goal is to simplify the path from awareness to diagnosis and treatment.
No. It runs through any standard web browser on a smartphone, tablet, or desktop with a camera. No wearable device, no overnight test, and no app download are required. The entire screening takes under 60 seconds.
Yes. All data is stored on secure, HIPAA-compliant US-based servers, encrypted at rest and in transit. Soliish also aligns with GDPR for international partners. Patient data is never used for marketing or resold to third parties.
Yes. Soliish supports HL7 and FHIR standards for EHR integration, as well as REST API, embedded SDK, iFrame deployment, and Zapier-based no-code workflows. Most integrations require no custom development.
Yes. Soliish offers flexible branding options - from co-branded experiences to fully white-labeled deployments with your domain and custom workflows. Contact our team to discuss your specific requirements.
Approximately 936 million people worldwide are affected by obstructive sleep apnea, with an estimated 80% remaining undiagnosed. The average time from symptom onset to clinical diagnosis is 2 to 5 years.
